The Value Signal — May 07, 2026

639 articles scanned · 14 high-signal

Signal Map

Executive Summary

VBC’s center of gravity is shifting from voluntary experimentation to enforced operating discipline, with CMS models, Medicare Advantage strain and specialty-sector economics forcing providers and payers to prove value under tighter rules.

Mandatory models and Medicare pressure are setting the pace: CMS’s TEAM model is being framed as a compulsory opportunity for health systems to redesign episode economics, according to MedCity News, while physicians in Congress are pushing a MIPS overhaul that signals ongoing dissatisfaction with legacy performance measurement, Beckersphysicianleadership reports. Medicare Advantage growth is raising fundamental questions about Medicare’s performance trajectory, Brookings reports, and payers are describing the current MA environment as unsustainable while prioritizing prior authorization reform and AI scaling, according to Becker's Payer.

Execution risk is now the VBC story. The ACCESS Model could trigger a health-tech land rush but also create serious market-entry obstacles, Health Affairs reports, while unused Medicare care-coordination codes are leaving patients exposed to preventable breakdowns in medication management, symptom escalation and follow-up, according to KevinMD. Sector-specific VBC remains uneven: autism therapy leaders warn value-based care will not automatically solve access and business-model problems, Bhbusiness reports; pharmacy models are showing quality gains, Drugtopics reports; and biosimilar adoption is increasingly tied to provider performance in Medicare value-based payment models, AJMC reports.